Literature DB >> 20515689

MDM4 binds ligands via a mechanism in which disordered regions become structured.

Maria C Sanchez1, Jonathan G Renshaw, Gareth Davies, Paul N Barlow, Martin Vogtherr.   

Abstract

MDM2 and MDM4 are proteins involved in regulating the tumour suppressor p53. MDM2/4 and p53 interact through their N-terminal domains and disrupting this interaction is a potential anticancer strategy. The MDM2-p53 interaction is structurally and biophysically well characterised, whereas equivalent studies on MDM4 are hampered by aggregation of the protein. Here we present the NMR characterization of MDM4 (14-111) both free and in complexes with peptide and small-molecule ligands. MDM4 is more dynamic in its apo state than is MDM2, with parts of the protein being unstructured. These regions become structured upon binding of a ligand. MDM4 appears to bind its ligand through conformational selection and/or an induced fit mechanism; this might influence rational design of MDM4 inhibitors. Copyright 2010 Federation of European Biochemical Societies. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515689     DOI: 10.1016/j.febslet.2010.05.058

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Autoinhibition of MDMX by intramolecular p53 mimicry.

Authors:  Lihong Chen; Wade Borcherds; Shaofang Wu; Andreas Becker; Ernst Schonbrunn; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

2.  Optimal Affinity Enhancement by a Conserved Flexible Linker Controls p53 Mimicry in MdmX.

Authors:  Wade Borcherds; Andreas Becker; Lihong Chen; Jiandong Chen; Lucía B Chemes; Gary W Daughdrill
Journal:  Biophys J       Date:  2017-05-06       Impact factor: 4.033

3.  Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction.

Authors:  Bing Shan; Da-Wei Li; Lei Brüschweiler-Li; Rafael Brüschweiler
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

4.  Ligand binding mode prediction by docking: mdm2/mdmx inhibitors as a case study.

Authors:  Nagakumar Bharatham; Kavitha Bharatham; Anang A Shelat; Donald Bashford
Journal:  J Chem Inf Model       Date:  2014-01-21       Impact factor: 4.956

5.  Thermodynamic and kinetic analysis of peptides derived from CapZ, NDR, p53, HDM2, and HDM4 binding to human S100B.

Authors:  Lucas N Wafer; Werner W Streicher; Scott A McCallum; George I Makhatadze
Journal:  Biochemistry       Date:  2012-08-29       Impact factor: 3.162

6.  Monitoring Ligand-Induced Protein Ordering in Drug Discovery.

Authors:  Christy R Grace; David Ban; Jaeki Min; Anand Mayasundari; Lie Min; Kristin E Finch; Lyra Griffiths; Nagakumar Bharatham; Donald Bashford; R Kiplin Guy; Michael A Dyer; Richard W Kriwacki
Journal:  J Mol Biol       Date:  2016-01-23       Impact factor: 5.469

7.  Identification of Secondary Binding Sites on Protein Surfaces for Rational Elaboration of Synthetic Protein Mimics.

Authors:  Justin M Torner; Yuwei Yang; David Rooklin; Yingkai Zhang; Paramjit S Arora
Journal:  ACS Chem Biol       Date:  2021-07-06       Impact factor: 4.634

8.  Leveraging the multivalent p53 peptide-MdmX interaction to guide the improvement of small molecule inhibitors.

Authors:  Xiyao Cheng; Rong Chen; Ting Zhou; Bailing Zhang; Zichun Li; Meng Gao; Yongqi Huang; Huili Liu; Zhengding Su
Journal:  Nat Commun       Date:  2022-02-28       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.